Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Healthcare expansion increases and centralizes the power of wealthy elites through stratifying access to coverage on macro, meso, and micro levels.

Adele E. Clarke et al. 2003 (Professor of Sociology and of History of Health Sciences at the University of California, San Francisco) “Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine” April 2003. May 28, 2017. (http://search.proquest.com.proxy.library.umkc.edu/docview/218770736?pq-origsite=summon&accountid=14589)

CENTRALIZATION, RATIONALIZATION, AND DEVOLUTION OF SERVICES. Centralization of facilities, health-care services, and corporate health-care coverage has been on the rise through the merger and acquisition of hospital facilities, insurers, physician groups, and pharmaceutical companies. This has resulted in the loss of many community, public, and not-for-profit facilities that either could not compete or were acquired expressly for closure. The underlying objectives are to boost the efficiency and uniformity of services, to centralize and rationalize decision-making about service provision, to capture more markets and arenas of health for profit, and to exert greater economic control within these arenas. In practice, Foucauldian panoptical patterns of physical decentralization with administrative centralization are common (Foucault 1975, 1991). These patterns are greatly facilitated by meso-level computer and information science practices and programs that automatically monitor highly dispersed developments for centralized management operations. Although such health-care consolidations bring some efficiency, they also pose numerous dangers as a result of corporate concentration. Such dangers include, for example, inflationary tendencies from the concentration of pricing power, new administrative burdens, and the enhanced political power of conglomerates. Such consolidations now exert significant leverage over political and regulatory processes, as well as decision-making that affects provider groups, patient care, and service options in highly stratified ways (Waitzkin 2001; Waitzkin and Fishman 1997). For example, in Northern California recently, Blue Cross (a health insurance company) and Sutter Health (a for-profit corporatized provider network) were locked in contractual conflicts over reimbursement rates. Because of Sutter's acquisition of large numbers of health-care facilities in the area, it was able to effectively deny services to many Blue Cross subscribers by not accepting Blue Cross insurance, eventually compelling the insurer to agree to higher rates. Devolution of health-care services also demonstrates the trend toward rationalization. That is, there are attempts to routinize and standardize health services while also shifting increasing proportions of the expensive labor of hands-on care to families and individuals (Timmermans and Berg 1997). Outpatient surgery, home health care, and elaborating subacute care facilities (e.g., skilled nursing facilities, nursing homes) are a few examples of devolution. Devolution also contributes to the fragmentation of health care and its geographic dispersal, making rationalizing more difficult. STRATIFIED BIOMEDICALIZATION. Morgan (1998) recently reasserted the unevenness and instabilities of medicalization processes, reminding us that medicalization was not monolithic and unidirectional but heterogeneous and fraught with paradoxical problems of exclusion, inclusion, participation, and resistances. Such arguments were initially elaborated in Ehrenreich and Ehrenreich's (1978) critical elucidation of the dual tendencies of medicalization. The first tendency, cooptative medicalization, refers to the jurisdictional expansion of modern medicine-extending into areas of life previously not deemed medical. The second tendency, exclusionary disciplining, refers to the simultaneous exclusionary actions of medicine that erect barriers to access to medical institutions and resources that target and affect particular individuals and segments of populations. Historically, these dual strategies have stratified the U.S. medical market by race, class, gender, and other attributes. For example, cooptative tendencies have long predominated for white middle- and upper-class groups, especially women, while exclusionary tendencies or particular kinds of cooptative medicalization (such as provision/imposition of birth control and sterilization) have prevailed for peoples of color and the poor (Riessman 1983; Ruzek 1980; Ruzek, Olesen, and Clarke 1997). Medicalization was stratified, and so too is biomedicalization. We term the reformulation and reconstitution of such processes in the biomedicalization era stratified biomedicalization.10 The cooptative and exclusionary tendencies noted above persist and become increasingly complex, and new modes of stratification are also produced. Even as technoscientific interventions extend their reach into ever more spaces, many people are completely by-passed, others impacted unevenly, and while some protest excessive biomedical intervention into their lives, others lack basic care. Such innovations are far from the goal of universally accessible and sustainable health care promoted by some bioethicists and others (e.g., Callahan 1998). Even rationalization itself is stratified, producing fragmentation. For example, availability of routine preventive care, screening services, pharmaceutical coverage, and "elective" services such as bone-marrow transplants or infertility treatments are differentially available depending on one's health insurance plan, or lack thereof. There are still over 1,000 different insurers in the United States, all providing different kinds of coverage, and thus, as a whole, the system is highly uncentralized, inefficient, and uncertain-the very things that, in theory, rationalization attempts to eliminate. In 2001, the share of the population wholly uninsured for the entire year rose to 14.6 percent or 41.2 million people up from 14.2 percent in 2000 and an increase of 1.4 million people (Mills 2002:1). In 2001 and 2002, about 75 million people under age 65 went without health insurance for at least one month; nearly 3 in 4 were in working families and more than half were white (Meckler 2003:A4). Cutbacks in government coverage of medical care are also widespread, and are being made in concert with reductions in a range of social services that affect the health status of individuals and groups down-stream. There has even been research on the efficacy of group medical appointments for the poor instead of (or with) short individual examinations (McInaney 2000). Such gate keeping becomes ever more imperative in efforts to make economic profits from increasingly expensive and highly technological procedures, and from providing services to less desirable but financially still necessary markets and population groups. At the same time, there are dramatic increases in stratifying fee-for-service options for those who can afford them. The most common and affordable alternatives are choosing high-end preferred providers through such an insurance plan. Here providers to whom you pay a higher co-payment are often more available (within weeks rather than months) and may have better reputations. Some plans offer high-end hospital options-you pay more to go to certain "better" hospitals. Out-of-pocket boutique medicine options usually range from cosmetic surgeries to new reproductive/conceptive technologies to some organ transplants. In addition, there are emerging options for "boutique or concierge primary care" based on privately paid annual fees to individual physicians in private practice. Here, individuals pay providers an annual amount (from a few thousand dollars to many thousands of dollars). In return they get appointments within 24 hours and for longer durations than the average patient, cell phone and e-mail access to their physicians, house calls, and so on. High-end versions (at about $13,000 per year) are located in chic spa-like offices with marble baths, terry robes, and complete privacy, and are being organized through franchises. This "concierge" model is popular with wealthy seniors, people with chronic illnesses, and the youthful rich (Heimer 2002). In short, even "good" medical insurance no longer ensures good primary care. In sum, the politico-economic transformations of the biomedical sector are massive and ongoing, ranging from macro structural moves by industries and corporations to meso- and micro-level changes in the concrete practices of health and medicine. Not only do such transformations produce new and elaborated mechanisms through which biomedicalization can occur, but also biomedicalization, in turn, drives and motivates many of these economic and organizational changes.

Sign in to recut, update, or save this card.